ELR+-CXC chemokines and their receptors in early metanephric development

Journal of the American Society of Nephrology

Volumn 18, Issue 8, 2007, Pages 2359-2370

  Levashova, Zoia B ^a   Sharma, Nirmala ^a   Timofeeva, Olga A ^a   Dome, Jeffrey S ^b   Perantoni, Alan O ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; ALPHA ACTIN; ALPHA CHEMOKINE; CD31 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR; CXCL2 CHEMOKINE; CXCL7 CHEMOKINE; GELATINASE B; MEGSIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; IMMUNOREGULATION; INFLAMMATION; KIDNEY CARCINOMA; KIDNEY DEVELOPMENT; MESANGIUM CELL; MESENCHYME CELL; MOUSE; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 34547670601     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006040380     Document Type: Article

References (55)

1. Karavanova ID, Dove LF, Resau JH, Perantoni AO: Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development 122: 4159-4167, 1996
2. Barasch J, Yang J, Ware CB, Taga T, Yoshida K, Erdjument-Bromage H, Tempst P, Parravicini E, Malach S, Aranoff T, Oliver JA: Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell 99: 377-386, 1999
3. Plisov SY, Yoshino K, Dove LF, Higinbotham KG, Rubin JS, Perantoni AO: TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. Development 128: 1045-1057, 2001
4. Perantoni A, Kan FW, Dove LF, Reed CD: Selective growth in culture of fetal rat renal collecting duct anlagen. Morphologic and biochemical characterization. Lab Invest 53: 589-596, 1985
5. Baggiolini M: Novel aspects of inflammation: Interleukin-8 and related chemotactic cytokines. Clin Investig 71: 812-814, 1993
6. Ludwig A, Petersen F, Zahn S, Gotze O, Schroder JM, Flad HD, Brandt E: The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90: 4588-4597, 1997
7. Wuyts A, Proost P, Lenaerts JP, Ben-Baruch A, Van Damme J, Wang JM: Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem 255: 67-73, 1998
8. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM: CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8, 2000
9. Mockenhaupt M, Peters F, Schwenk-Davoine I, Herouy Y, Schraufstatter I, Eisner P, Norgauer J: Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes. Int J Mol Med 12: 597-601, 2003
10. Li A, Dubey S, Varney ML, Dave BJ, Singh RK: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170: 3369-3376, 2003
11. Maheshwari A, Lu W, Lacson A, Barleycorn AA, Nolan S, Christensen RD, Calhoun DA: Effects of interleukin-8 on the developing human intestine. Cytokine 20: 256-267, 2002
12. Ragozzino D: CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development. J Neurovirol 8: 559-572, 2002
13. Perantoni AO, Dove L, Karavanova I: Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci U S A 92: 4696-4700, 1995
14. Rogers SA, Ryan G, Hammerman MR: Metanephric transforming growth factor-alpha is required for renal organogenesis in vitro. Am J Physiol 262: F533-F539, 1992
15. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 83: 7297-7301, 1986
16. Vinals F, Pouyssegur J: Transforming growth factor betal (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol 21: 7218-7230, 2001
17. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM: Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273: 10095-10098, 1998
18. Lelongt B, Trugnan G, Murphy G, Ronco PM: Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136: 1363-1373, 1997
19. Lambert V, Munaut C, Jost M, Noel A, Werb Z, Foidart JM, Rakic JM: Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol 161: 1247-1253, 2002
20. Zhu YM, Webster SJ, Flower D, Woll PJ: Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 91: 1970-1976, 2004
21. Li A, Varney ML, Singh RK: Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype. Clin Exp Metastasis 21: 571-579, 2004
22. Varney ML, Johansson SL, Singh RK: Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol 125: 209-216, 2006
23. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11: 152-176, 2000
24. Chuntharapai A, Lee J, Hebert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153: 5682-5688, 1994
25. Schulz BS, Michel G, Wagner S, Suss R, Beetz A, Peter RU, Kemeny L, Ruzicka T: Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol 151: 4399-4406, 1993
26. Kondo S, Yoneta A, Yazawa H, Kamada A, Jimbow K: Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB. J Cell Physiol 182: 366-370, 2000
27. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC: Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882-2890, 1997
28. Tecimer T, Dlott J, Chuntharapai A, Martin AW, Peiper SC: Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells. Arch Pathol Lab Med 124: 520-525, 2000
29. Nguyen D, Stangel M: Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res Dev Brain Res 128: 77-81, 2001
30. Dame JB, Juul SE: The distribution of receptors for the pro-inflammatory cytokines interleukin (IL)-6 and IL-8 in the developing human fetus. Early Hum Dev 58: 25-39, 2000
31. Luan J, Furuta Y, Du J, Richmond A: Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. Cytokine 14: 253-263, 2001
32. Samanta AK, Oppenheim JJ, Matsushima K: Identification and characterization of specific receptors for monocyte-derived neutrophil chemotactic factor (MDNCF) on human neutrophils. J Exp Med 169: 1185-1189, 1989
33. Tikhonov II, Fomin IK, Doroshenko TM, Chalyi IuV, Voitenok NN: Expression of cDNA for human interleukin-8 type one receptor in BALB 3T3 fibroblasts and characteristics of products of expression [in Russian]. Mol Biol (Mosk) 30: 1014-1021, 1996
34. Ludwig A, Ehlert JE, Flad HD, Brandt E: Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression. J Immunol 165: 1044-1052, 2000
35. Stuart RO, Bush KT, Nigam SK: Changes in gene expression patterns in the ureteric bud and metanephric mesenchyme in models of kidney development. Kidney Int 64: 1997-2008, 2003
36. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B: High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A 89: 10542-10546, 1992
37. Hyink DP, Tucker DC, St John PL, Leardkamolkarn V, Accavitti MA, Abrass CK, Abrahamson DR: Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am J Physiol 270: F886-F899, 1996
38. Shweiki D, Itin A, Softer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992
39. A Chuntharapai A, Kim KJ: Regulation of the expression of IL-8 receptor A/B by IL-8: Possible functions of each receptor. J Immunol 155: 2587-2594, 1995
40. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G: Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96: 2673-2681, 2000
41. Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D: FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293: 1174-1182, 2002
42. Ganser GL, Stricklin GP, Matrisian LM: EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 35: 453-461, 1991
43. Poladia DP, Kish K, Kutay B, Hains D, Kegg H, Zhao H, Bates CM: Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme. Dev Biol 291: 325-339, 2006
44. Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL: Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem 271: 2832-2838, 1996
45. Limatola C, Ciotti MT, Mercanti D, Santoni A, Eusebi F: Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival. J Neuroimmunol 123: 9-17, 2002
46. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK: Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8: 63-71, 2005
47. Basson MA, Watson-Johnson J, Shakya R, Akbulut S, Hyink D, Costantini FD, Wilson PD, Mason IJ, Licht JD: Branching morphogenesis of the ureteric epithelium during kidney development is coordinated by the opposing functions of GDNF and Sproutyl. Dev Biol 299: 466-477, 2006
48. Merz D, Liu R, Johnson K, Terkeltaub R: IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol 171: 4406-4415, 2003
49. Emadi S, Clay D, Desterke C, Guerton B, Maquarre E, Charpentier A, Jasmin C, Le Bousse-Kerdiles MC; French INSERM Research Network on MMM: IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocyte proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis. Blood 105: 464-473, 2005
50. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM: Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 172: 2853-2860, 2004
51. Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM: The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 175: 5351-5357, 2005
52. Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A: Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 115: 234-244, 2000
53. Moepps B, Nuesseler E, Braun M, Gierschik P: A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol Immunol 43: 897-914, 2006
54. Levashova ZB, Plisov SY, Perantoni AO: Conditionally immortalized cell line of inducible metanephric mesenchyme. Kidney Int 63: 2075-2087, 2003
55. Tuttle R, Nakagawa Y, Johnson JE, O'Leary DDM: Defects in thalamocortical axon pathfinding correlate with altered cell domains in Mash-1-deficient mice. Development 126: 1903-1916, 1999